IDEAS home Printed from https://ideas.repec.org/a/inm/ordeca/v3y2006i4p197-207.html
   My bibliography  Save this article

A Bayesian Decision-Theoretic Dose-Finding Trial

Author

Listed:
  • Peter Müller

    (Department of Biostatistics, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 447, Houston, Texas 77030)

  • Don A. Berry

    (Department of Biostatistics, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 447, Texas 77030)

  • Andrew P. Grieve

    (Department of Public Health Sciences, King’s College, London WC2R 2LS, United Kingdom)

  • Michael Krams

    (Wyeth Pharmaceuticals, 500 Arcola Road, Collegeville, Pennsylvania 19426)

Abstract

We describe the use of a successful combination of Bayesian inference and decision theory in a clinical trial design. The trial involves three important decisions, adaptive dose allocation, optimal stopping of the trial, and the optimal terminal decision upon stopping. For all three decisions we use a formal Bayesian decision-theoretic approach. The application demonstrates how Bayesian posterior inference and decision-theoretic approaches combine to provide a coherent solution in a complex application. The main challenges are the need for a flexible probability model for the unknown dose-response curve, a delayed response, the sequential nature of the stopping decision, and the complex considerations involved in the terminal decision. The main methodological features of the proposed solution are the use of decision theory to achieve optimal learning about the unknown dose-response curve, an innovative grid-based approximation method to implement backward induction for the sequential stopping decision, and a utility function for the terminal decision that is based on a posterior predictive description of a future confirmatory trial.

Suggested Citation

  • Peter Müller & Don A. Berry & Andrew P. Grieve & Michael Krams, 2006. "A Bayesian Decision-Theoretic Dose-Finding Trial," Decision Analysis, INFORMS, vol. 3(4), pages 197-207, December.
  • Handle: RePEc:inm:ordeca:v:3:y:2006:i:4:p:197-207
    DOI: 10.1287/deca.1060.0079
    as

    Download full text from publisher

    File URL: http://dx.doi.org/10.1287/deca.1060.0079
    Download Restriction: no

    File URL: https://libkey.io/10.1287/deca.1060.0079?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Nigel Stallard, 2003. "Decision-Theoretic Designs for Phase II Clinical Trials Allowing for Competing Studies," Biometrics, The International Biometric Society, vol. 59(2), pages 402-409, June.
    2. Scott M. Berry & Joseph B. Kadane, 1997. "Optimal Bayesian Randomization," Journal of the Royal Statistical Society Series B, Royal Statistical Society, vol. 59(4), pages 813-819.
    3. Guosheng Yin & Yisheng Li & Yuan Ji, 2006. "Bayesian Dose-Finding in Phase I/II Clinical Trials Using Toxicity and Efficacy Odds Ratios," Biometrics, The International Biometric Society, vol. 62(3), pages 777-787, September.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. L. Robin Keller & Ali Abbas & J. Eric Bickel & Vicki M. Bier & David V. Budescu & John C. Butler & Enrico Diecidue & Robin L. Dillon-Merrill & Raimo P. Hämäläinen & Kenneth C. Lichtendahl & Jason R. W, 2012. "From the Editors ---Brainstorming, Multiplicative Utilities, Partial Information on Probabilities or Outcomes, and Regulatory Focus," Decision Analysis, INFORMS, vol. 9(4), pages 297-302, December.
    2. L. Robin Keller, 2010. "From the Editor..," Decision Analysis, INFORMS, vol. 7(3), pages 235-237, September.
    3. Ryan, Elizabeth G. & Drovandi, Christopher C. & Thompson, M. Helen & Pettitt, Anthony N., 2014. "Towards Bayesian experimental design for nonlinear models that require a large number of sampling times," Computational Statistics & Data Analysis, Elsevier, vol. 70(C), pages 45-60.
    4. L. Robin Keller & Ali Abbas & J. Eric Bickel & Vicki M. Bier & David V. Budescu & John C. Butler & Philippe Delquié & Kenneth C. Lichtendahl & Jason R. W. Merrick & Ahti Salo & George Wu, 2011. "From the Editors ---Probability Scoring Rules, Ambiguity, Multiattribute Terrorist Utility, and Sensitivity Analysis," Decision Analysis, INFORMS, vol. 8(4), pages 251-255, December.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Haitao Pan & Ping Huang & Zuoren Wang & Ling Wang & Chanjuan Li & Jielai Xia, 2013. "A Novel Bayesian Seamless Phase I/II Design," PLOS ONE, Public Library of Science, vol. 8(9), pages 1-6, September.
    2. Ying Kuen Cheung, 2014. "Simple benchmark for complex dose finding studies," Biometrics, The International Biometric Society, vol. 70(2), pages 389-397, June.
    3. F. P. A. Coolen & P Coolen-Schrijner, 2006. "On Zero-Failure Testing for Bayesian High-Reliability Demonstration," Journal of Risk and Reliability, , vol. 220(1), pages 35-44, June.
    4. Peter F. Thall & Hoang Q. Nguyen & Ralph G. Zinner, 2017. "Parametric dose standardization for optimizing two-agent combinations in a phase I–II trial with ordinal outcomes," Journal of the Royal Statistical Society Series C, Royal Statistical Society, vol. 66(1), pages 201-224, January.
    5. Ying Yuan & Guosheng Yin, 2009. "Bayesian dose finding by jointly modelling toxicity and efficacy as time‐to‐event outcomes," Journal of the Royal Statistical Society Series C, Royal Statistical Society, vol. 58(5), pages 719-736, December.
    6. José L. Jiménez & Mourad Tighiouart, 2022. "Combining cytotoxic agents with continuous dose levels in seamless phase I‐II clinical trials," Journal of the Royal Statistical Society Series C, Royal Statistical Society, vol. 71(5), pages 1996-2013, November.
    7. Yuxi Tao & Junlin Liu & Zhihui Li & Jinguan Lin & Tao Lu & Fangrong Yan, 2013. "Dose-Finding Based on Bivariate Efficacy-Toxicity Outcome Using Archimedean Copula," PLOS ONE, Public Library of Science, vol. 8(11), pages 1-6, November.
    8. Drovandi, Christopher C. & McGree, James M. & Pettitt, Anthony N., 2013. "Sequential Monte Carlo for Bayesian sequentially designed experiments for discrete data," Computational Statistics & Data Analysis, Elsevier, vol. 57(1), pages 320-335.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:inm:ordeca:v:3:y:2006:i:4:p:197-207. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Chris Asher (email available below). General contact details of provider: https://edirc.repec.org/data/inforea.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.